FUSEN PHARMACEUTICAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.89 HKD | 0.00% |
|
+2.30% | -35.04% |
| Sales 2021 | 386M 53.27M 416M 4.26B | Sales 2022 | 492M 67.93M 531M 5.43B | Capitalization | 958M 132M 1.03B 10.57B |
|---|---|---|---|---|---|
| Net income 2021 | 16M 2.21M 17.28M 177M | Net income 2022 | -34M -4.7M -36.71M -375M | EV / Sales 2021 | 2.41 x |
| Net Debt 2021 | 159M 21.96M 172M 1.76B | Net Debt 2022 | 100M 13.85M 108M 1.11B | EV / Sales 2022 | 2.15 x |
| P/E ratio 2021 |
50.5
x | P/E ratio 2022 |
-25.3
x | Employees | 1,148 |
| Yield 2021 |
0.9% | Yield 2022 |
-
| Free-Float | 22.24% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | +2.30% | ||
| Current month | -2.20% | ||
| 1 month | -1.11% | ||
| 3 months | -35.04% | ||
| 6 months | -40.67% | ||
| Current year | -35.04% |
1 week
0.76
0.95
1 month
0.761.00
Current year
0.761.39
1 year
0.761.60
3 years
0.764.70
5 years
0.7620.00
10 years
0.7620.00
| Managers | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 46 | 17/04/19 |
Zhi Ming Cao
BRD | Director/Board Member | 38 | 17/01/13 |
Tik Man Wong
SEC | Corporate Secretary | 43 | 28/01/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kwok Tung Lee
BRD | Director/Board Member | 56 | 14/04/19 |
Chang Cheng Cao
CHM | Chairman | 67 | 19/11/16 |
Tai Sheng Hou
BRD | Director/Board Member | 61 | 06/04/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/05/24 | 0.89 | 0.00% | 542 000 |
| 30/04/24 | 0.89 | 0.00% | 0 |
| 29/04/24 | 0.89 | -1.11% | 498,000 |
| 26/04/24 | 0.9 | +3.45% | 122,000 |
| 25/04/24 | 0.87 | 0.00% | 0 |
Delayed Quote Hong Kong S.E., May 02, 2024 at 09:08 am
More quotes
Fusen Pharmaceutical Co Ltd is a China-based company principally engaged in the provision of Shuanghuanglian series cold medicines. The Company is mainly engaged in research, development, production and sales of Chinese patent drugs and western medicine products for the treatment of cold and fever, cardiovascular diseases and anemia. The Company's main products include small volume injections, oral liquids, tablets, capsules and granules. The Company distributes its products mainly in domestic market.
Sector
Pharmaceuticals
Calendar
27/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -35.04% | 84.1M | |
| +20.61% | 43.18B | |
| +20.67% | 22.59B | |
| +15.34% | 14.56B | |
| +13.94% | 13.54B | |
| +43.35% | 11.5B | |
| -8.37% | 6.93B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.36B |
- Stock Market
- Equities
- 1652 Stock
